021-51111890
购物车（）
sales@molnova.cn
Mutated EGFR-IN-1
CAS No. 1421372-66-8
Mutated EGFR-IN-1 ( Osimertinib analog )
产品货号. M23574 CAS No. 1421372-66-8
突变EGFR-IN-1是突变EGFR抑制剂设计的有用中间体，例如L858R EGFR、Exon19缺失激活突变体和T790M抗性突变体。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥107 | 有现货 |
|
| 5MG | ￥155 | 有现货 |
|
| 10MG | ￥235 | 有现货 |
|
| 25MG | ￥368 | 有现货 |
|
| 50MG | ￥483 | 有现货 |
|
| 100MG | ￥655 | 有现货 |
|
| 500MG | ￥1728 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ￥212 | 有现货 |
|
生物学信息
-
产品名称Mutated EGFR-IN-1
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述突变EGFR-IN-1是突变EGFR抑制剂设计的有用中间体，例如L858R EGFR、Exon19缺失激活突变体和T790M抗性突变体。
-
产品描述Mutated EGFR-IN-1 is a useful intermediate for the inhibitors design for mutated EGFR, such as L858R EGFR, Exonl9 deletion activating mutant, and T790M resistance mutant.
-
体外实验——
-
体内实验——
-
同义词Osimertinib analog
-
通路Angiogenesis
-
靶点EGFR
-
受体EGFR (L858R)|EGFR (T790M)|EGFR(Exon 19 deletion/T790M)
-
研究领域——
-
适应症——
化学信息
-
CAS Number1421372-66-8
-
分子量445.56
-
分子式C25H31N7O
-
纯度>98% (HPLC)
-
溶解度DMSO: 75 mg/mL (168.33 mM)
-
SMILESNC1=CC(NC2=NC=CC(C3=CN(C)C4=C3C=CC=C4)=N2)=C(OC)C=C1N(CCN(C)C)C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Patent WO 2013014448 A2 - (2, 4, 5 - substituted -anilino) pyrimidine derivatives as egfr modulators useful for treating cancer .
产品手册
关联产品
-
Chrysophanic Acid
提取自大黄（Rheum palmatum L.）；适用性：沸腾的乙醇、苯、氯仿、乙醚、乙酸和丙酮。
-
HER2 neu (654-662) G...
Affibody (affibody) ligands that are specific for the extracellular domain of human epidermal growth factor receptor 2 (HER2/neu) have been selected by phage display technology from a combinatorial protein library based on the 58 amino acid residue staphylococcal protein A-derived Z domain.
-
(Rac)-JBJ-04-125-02
JBJ-04-125-02 作为单药在 EGFR 突变型肺癌的体外和体内模型中均有效。
